• La France à l’honneur: essai RETREAT-FRAIL Reduction of Antihypertensive Treatment in Nursing Home Residents. Benetos A, et al. Published on August 29, 2025, at NEJM.org. DOI: 10.1056/NEJMoa2508157. LIRE
  • Nouvelles recommandations US, AC/AHA dans l’HTA publiées conjointement dans Circulation et Hypertension 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Jones DW, et al. Circulation. 2025 Aug 14. doi: 10.1161/CIR.0000000000001356 LIRE
  • Nouvelle recommandation : 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy LIRE
  • Efficacy and Safety of Baxdrostat in uncontrolled and resistant hypertension. Flack JM et al. N Engl J Med 2025 Aug 30. doi: 10.1056/NEJMoa2507109. Online ahead of print LIRE
  • Efficacy and safety of sacubitril/valsartan in Afro-descendant patients with resistant hypertension: a randomized controlled trial. Bitar YSL, et al. J Hypertens. 2025 Sep 1;43(9):1485-1491. doi: 10.1097/HJH.0000000000004075 LIRE
  • Blood pressure-lowering efficacy of antihypertensive drugs and their combinations: a systematic review and meta-analysis of randomised, double-blind, placebo-controlled trials. Wang N, et al. Lancet. 2025 Aug 30;406(10506):915-925. doi: 10.1016/S01406736(25)00991-2 LIRE